PharmaCielo Ltd. PCLOF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.50% | 42.80% | 127.22% | 48.09% | 50.03% |
| Total Depreciation and Amortization | -64.37% | 108.82% | 52.35% | 400.00% | 465.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.25% | -782.83% | -77.15% | -44.77% | -53.84% |
| Change in Net Operating Assets | -103.36% | -96.64% | -3,712.04% | -46,664.15% | 934.46% |
| Cash from Operations | -110.77% | -1,063.96% | 377.28% | -532.39% | 445.85% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 10,582.97% | -- | -- | -- |
| Total Debt Issued | 92.00% | -71.60% | -71.04% | -- | -81.34% |
| Total Debt Repaid | -- | 100.00% | 151.18% | -5,280.50% | -492.20% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 111.10% | -61.94% | -20.60% | -769.73% | -552.70% |
| Foreign Exchange rate Adjustments | 673.33% | -245.31% | 188.89% | 2,120.00% | 54.55% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 225.87% | -1,345.91% | -73.29% | 1,828.57% | 65.77% |